Position in IXHL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$557,149
+$343,615 QoQ
Shares Held
148,178
+108.2% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 15 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IXHL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names. IXHL ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in IXHL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,149 | 148,178 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $213,534 | 71,178 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $120,063 | 335,373 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $21,053 | 45,373 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $69,962 | 323,900 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||